148 related articles for article (PubMed ID: 1693001)
1. Interaction of glucagon-like peptide-1 (7-36)amide and cholecystokinin-8 in the endocrine and exocrine rat pancreas.
Fehmann HC; Göke B; Weber V; Göke R; Trautmann ME; Richter G; Arnold R
Pancreas; 1990 May; 5(3):361-5. PubMed ID: 1693001
[TBL] [Abstract][Full Text] [Related]
2. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
[TBL] [Abstract][Full Text] [Related]
3. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.
Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941
[TBL] [Abstract][Full Text] [Related]
4. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas.
Fehmann HC; Göke B; Göke R; Trautmann ME; Arnold R
FEBS Lett; 1989 Jul; 252(1-2):109-12. PubMed ID: 2668027
[TBL] [Abstract][Full Text] [Related]
5. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.
Otsuki M; Sakamoto C; Yuu H; Maeda M; Morita S; Ohki A; Kobayashi N; Terashi K; Okano K; Baba S
J Clin Invest; 1979 Mar; 63(3):478-84. PubMed ID: 372241
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
[TBL] [Abstract][Full Text] [Related]
7. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
[TBL] [Abstract][Full Text] [Related]
8. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide.
Komatsu R; Matsuyama T; Namba M; Watanabe N; Itoh H; Kono N; Tarui S
Diabetes; 1989 Jul; 38(7):902-5. PubMed ID: 2661287
[TBL] [Abstract][Full Text] [Related]
9. The effects of two FMRFamide related peptides (A-18-F-amide and F-8-F-amide; 'morphine modulating peptides') on the endocrine and exocrine rat pancreas.
Fehmann HC; McGregor G; Weber V; Eissele R; Göke R; Göke B; Arnold R
Neuropeptides; 1990 Oct; 17(2):87-92. PubMed ID: 1704109
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro.
Guenifi A; Ahrén B; Abdel-Halim SM
Pancreas; 2001 Jan; 22(1):58-64. PubMed ID: 11138972
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas.
Suzuki S; Kawai K; Ohashi S; Mukai H; Yamashita K
Endocrinology; 1989 Dec; 125(6):3109-14. PubMed ID: 2684616
[TBL] [Abstract][Full Text] [Related]
12. Effect of pancreastatin on pancreatic endocrine and exocrine secretion.
Ishizuka J; Asada I; Poston GJ; Lluis F; Tatemoto K; Greeley GH; Thompson JC
Pancreas; 1989; 4(3):277-81. PubMed ID: 2471966
[TBL] [Abstract][Full Text] [Related]
13. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K
Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
[TBL] [Abstract][Full Text] [Related]
14. Glucagonlike peptide I (7-37) actions on endocrine pancreas.
Weir GC; Mojsov S; Hendrick GK; Habener JF
Diabetes; 1989 Mar; 38(3):338-42. PubMed ID: 2645190
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of pirenzepine on cholecystokinin and secretin stimulation on exocrine and endocrine rat pancreas.
Otsuki M; Okabayashi Y; Nakamura T; Fujii M; Oka T; Tani S; Baba S
Dig Dis Sci; 1987 Oct; 32(10):1136-44. PubMed ID: 2443324
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.
Kawai K; Suzuki S; Ohashi S; Mukai H; Ohmori H; Murayama Y; Yamashita K
Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338
[TBL] [Abstract][Full Text] [Related]
17. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.
Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA
Am J Physiol; 1995 May; 268(5 Pt 1):E949-55. PubMed ID: 7762650
[TBL] [Abstract][Full Text] [Related]
18. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.
Inoue K; Hisatomi A; Umeda F; Nawata H
Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone.
Matsuyama T; Komatsu R; Namba M; Watanabe N; Itoh H; Tarui S
Diabetes Res Clin Pract; 1988 Oct; 5(4):281-4. PubMed ID: 3069410
[TBL] [Abstract][Full Text] [Related]
20. Islet amyloid polypeptide (IAPP;amylin) influences the endocrine but not the exocrine rat pancreas.
Fehmann HC; Weber V; Göke R; Göke B; Eissele R; Arnold R
Biochem Biophys Res Commun; 1990 Mar; 167(3):1102-8. PubMed ID: 1690993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
